CEQUINOR   05415
CENTRO DE QUIMICA INORGANICA "DR. PEDRO J. AYMONINO"
Unidad Ejecutora - UE
artículos
Título:
“Selective hypoxia-cytotoxins based on vanadyl complexes with 3-aminoquinoxaline-2-carbonitrile-N1,N4-dioxide derivatives”.
Autor/es:
MARISOL VIEITES; PABLA NOBLÍA; MARÍA H. TORRE; HUGO CERECETTO; ANTONIO J. DA COSTA FILHO; AMAIA AZQUETA; ADELA LÓPEZ DE CERAIN; ANTONIO MONGE; BEATRIZ PARAJÓN-COSTA; MERCEDES GONZÁLEZ; DINORAH GAMBINO
Revista:
JOURNAL OF INORGANIC BIOCHEMISTRY
Referencias:
Año: 2006 vol. 100 p. 1358 - 1358
ISSN:
0162-0134
Resumen:
 A new vanadyl complex with the formula VO(L1)2, where L1 = 3-amino-6(7)-chloroquinoxaline-2-carbonitrile N1,N4-dioxide, has been synthesized and characterized by elemental analyses, conductimetry , fast atom bombardmentr mass spectroscopy (FAB-MS) and electronic, Fourier transform infrared (FTIR), Raman,  nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) spectroscopies. Results were compared with those previously reported for analogous vanadium complexes with other 3-aminoquinoxaline-2-carbonitrile N1,N4-dioxide derivatives as ligands. As an effort to develop novel metal-based selective hypoxia-cytotoxins and to improve bioavailability and pharmacological and toxicological properties of aminoquinoxaline carbonitrile N-dioxides bioreductive prodrugs, the new complex and VO(L)2 complexes, with L = 3-amino-6(7)-bromoquinoxaline-2-carbonitrile N1,N4-dioxide(L2) and 3-amino-6(7)-methylquinoxaline-2-carbonitrile N1,N4-dioxide(L3), were subjected to cytotoxic evaluation in V79 cells in hypoxic and aerobic conditions. The complexes resulted in vitro more potent cytotoxins than the free ligands (ie potencies (PVO(L1)2 = 3.0, PL1 = 9.0mM) and Tirapazamine ( P = 30mM ) and showed excellent selective cytotoxicity in hypoxia, being no cytotoxic in oxia. In addition, the solubility in hydrophilic solvents resulted significantly higher for the vanadyl complexes than for the free ligands. These results could be indicative that complexation of the quinoxaline-2-carbonitrile N1,N4-dioxide derivatives with vanadium would improve their bioavailability. In addition, a new aspect of the series has been investigated. A detailed comparison of the electrochemical behavior of the free ligands and the complexes has been performed searching for a correlation between reduction potentials of the complexes and their activities and hypoxia selectivities.